rs398123765
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The ENST00000410020.8(DYSF):โc.1380+2T>C variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000411 in 1,460,902 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (โ โ ).
Frequency
Genomes: not found (cov: 33)
Exomes ๐: 0.0000041 ( 0 hom. )
Consequence
DYSF
ENST00000410020.8 splice_donor
ENST00000410020.8 splice_donor
Scores
3
3
1
Splicing: ADA: 0.9999
2
Clinical Significance
Conservation
PhyloP100: 7.67
Genes affected
DYSF (HGNC:3097): (dysferlin) The protein encoded by this gene belongs to the ferlin family and is a skeletal muscle protein found associated with the sarcolemma. It is involved in muscle contraction and contains C2 domains that play a role in calcium-mediated membrane fusion events, suggesting that it may be involved in membrane regeneration and repair. In addition, the protein encoded by this gene binds caveolin-3, a skeletal muscle membrane protein which is important in the formation of caveolae. Specific mutations in this gene have been shown to cause autosomal recessive limb girdle muscular dystrophy type 2B (LGMD2B) as well as Miyoshi myopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.01619497 fraction of the gene. Cryptic splice site detected, with MaxEntScore 5.7, offset of -21, new splice context is: gagGTcagc. Cryptic site results in inframe change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-71528403-T-C is Pathogenic according to our data. Variant chr2-71528403-T-C is described in ClinVar as [Pathogenic]. Clinvar id is 94266.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-71528403-T-C is described in Lovd as [Pathogenic]. Variant chr2-71528403-T-C is described in Lovd as [Likely_pathogenic]. Variant chr2-71528403-T-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYSF | NM_001130987.2 | c.1380+2T>C | splice_donor_variant | ENST00000410020.8 | NP_001124459.1 | |||
DYSF | NM_003494.4 | c.1284+2T>C | splice_donor_variant | ENST00000258104.8 | NP_003485.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYSF | ENST00000258104.8 | c.1284+2T>C | splice_donor_variant | 1 | NM_003494.4 | ENSP00000258104 | A1 | |||
DYSF | ENST00000410020.8 | c.1380+2T>C | splice_donor_variant | 1 | NM_001130987.2 | ENSP00000386881 | A1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250674Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135474
GnomAD3 exomes
AF:
AC:
4
AN:
250674
Hom.:
AF XY:
AC XY:
2
AN XY:
135474
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1460902Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 726792
GnomAD4 exome
AF:
AC:
6
AN:
1460902
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
726792
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ExAC
AF:
AC:
2
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 08, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 21, 2017 | The c.1284+2 T>C splice site variant in the DYSF gene has been previously reported as a homozygous variant in an individual with Miyoshi myopathy and dysferlin deficiency by immunohistochemistry and Western blot analysis (Tagawa et al., 2003). Due to use of alternative nomenclature, this variant was reported as c.1657+2 T>C (Tagawa et al., 2013). Subsequently, the c.1284+2 T>C variant has been reported as a common pathogenic variant in Korean dyferlinopathy patients (Shin et al., 2015). The c.1284+2 T>C variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). This pathogenic variant destroys the canonical splice donor site in intron 13, and is expected to cause abnormal gene splicing. - |
Autosomal recessive limb-girdle muscular dystrophy type 2B Pathogenic:1
Pathogenic, no assertion criteria provided | research | Department of Rehabilitation Medicine, Incheon St. Maryโs Hospital, College of Medicine, The Catholic University of Korea | Feb 11, 2019 | The proband has another variant, NM_003494.3: c.5303G>A (p.Arg1768Gln). - |
Miyoshi muscular dystrophy 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 01, 2024 | - - |
Qualitative or quantitative defects of dysferlin Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 03, 2022 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 94266). Disruption of this splice site has been observed in individuals with DYSF-related conditions (PMID: 33215690). This variant is present in population databases (rs398123765, gnomAD 0.02%). This sequence change affects a donor splice site in intron 13 of the DYSF gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
MutationTaster
Benign
D;D;D;D;D;D;D;D;D;D;D
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -23
DS_DL_spliceai
Position offset: -2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at